CME Podcast: Expanding Access to Treatment for Opioid Use Disorder
Credit Designation Statement
The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CME Released: August 5, 2022 CME Expiration: August 4, 2023
Upon completion of this activity, participants will be able to:
- Comprehend and explain the impact of the findings of the X:BOT study.
- Describe primary care-based treatment models for OUD.
- Explain the mechanism of action for OUD treatment options (e.g., methadone).
This activity is intended for psychiatrists, primary care physicians, nurse practitioners, physician assistants, nurses, and other clinicians who manage patients with opioid use disorder.
Method of Participation (Enduring)
This activity will take approximately 15 minutes to complete. To receive credit, participants are required to view the online activity and complete the posttest and evaluation. To receive credit, 100% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.
Sponsored by the Academy for Continued Healthcare Learning (ACHL) and SIMmersion.
This resource was funded in part with federal funds from the National Institute on Drug Abuse, Center for the Clinical Trials Network Dissemination Initiative (contract # 75N95020C00028RFP). The content was developed by experts and researchers and does not necessarily reflect the official position of the National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. government. This information should not be considered a substitute for legal counsel or individualized patient care and treatment decisions.
The content for this activity was developed independently and all materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher.
This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers' prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
Joint Providership Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning (ACHL) and SIMmersion. ACHL is accredited by the ACCME to provide continuing medical education for physicians.
Joshua D. Lee, MD, MSc
NYU Langone Health
New York, New York
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been mitigated prior to this activity.
The following financial relationships have been provided:
Joshua D. Lee, MD, MSc
Advisory Board: OAR Health
Grants/Research Support: Indivior
In-kind Donation: Alkermes and Indivior
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None
ACHL staff members, SIMmersion staff members, and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.